Synaffix Adcs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synaffix Adcs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synaffix Adcs Today - Breaking & Trending Today

Synaffix lines up $586M pact with MacroGenics en route to 'one-stop shop' for ADC tech

Published: February 3, 2022

Add cancer-focused biotech MacroGenics to the list of biopharmas shoveling out cash for Synaffix's antibody-drug conjugate technology. The Maryland biotech will dish out up to $586 million for access to Synaffix's ADCs for three programs.

Source: fiercebiotech.com

Related Topics:

United StatesUnited KingdomInnovent BiologicsJohnson JanssenSynaffix AdcsZai LabI Mab BiopharmaMersana TherapeuticsKyowa KirinShanghai MiracogenAntibody Drug ConjugatesCollaboration AgreementLicensing Deals